Novo Nordisk CSO Outlines Obesity R&D Strategy, Calls Condition "Ticking Time Bomb"

 
• By Sten Stovall
Obesity
Obesity "a global time bomb" Novo Nordisk CSO warms • Source: Shutterstock

More from Strategy

More from Business